Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
15,20 Serious GI AEs, though uncommon, have also been reported with GLP-1 RA therapy, including gastroparesis, intestinal obstruction, pancreatitis, and colonic ischemia
Studies using similar probiotic cocktails [82, 235, 236] as discussed in this review link these changes to recovery of gut-barrier function, thus preventing inflammation via translocation across the barrier [237]
The methylation of DNA plays a crucial role in regulating gene expression and maintaining genomic stability
Glutathione is known as the master antioxidant that fights off free radicals and helps improve the health of the skin